psychedelic clinical trials Archives

Tag Archive for: psychedelic clinical trials

Over One-Third of Under 50s Open to Psychedelic Trials for Mental Health Treatment

Over One-Third of Under 50s Are Open to Psychedelic Trials for Mental Health Treatment

Aside from psilocybin, those aged between 18-24 were most interested psychedelic trials with ketamine (27%) and MDMA (26%).

UK Psychedelic Trials Start-Up Issues National Call for Volunteers to Trial Innovative Medicines for Mental Health Disorders

Research

Clerkenwell Health is today issuing a national call for volunteers to step forward for upcoming trials testing psychedelic drugs.

The FDA Issues Guidance on Designing Psychedelic Clinical Trials

Research

The Food and Drug Administration published a new draft guidance with the purpose to advise researchers on study design when investigating the potential of psychedelics.

Will the UK’s Ambitious Life Sciences Investment Power-Up the Psychedelic Sector?

Culture, Treatment

As an emerging innovative sector addressing unmet mental health needs, psychedelic drug developers are poised to greatly benefit from the diverse initiatives offered within this package.

Want to Try Psychedelics in a Clinical Setting? 116 Trials Now Recruiting Volunteers (UPDATED)

Beginners, Treatment

Here's how to become a research subject for psilocybin, LSD, MDMA, ibogaine, DMT and 5-MeO-DMT studies.

Brain Scanning Technology to be Used for Psychedelic Clinical Trials in Pioneering London Start-Up Partnership

Business, Research

A start-up partnership between Clerkenwell Health and MYndspan will use brain scanning technology for psychedelic clinical trials.

Psychedelic Business Spotlight – June 3

Business, Stock Reports

This week in psychedelic business news: Cybin moves towards clinical trials; Braxia releases data on treating depression with psilocybin; Clearmind files for a new patent; and much more!